AR015917A1 - COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA - Google Patents

COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA

Info

Publication number
AR015917A1
AR015917A1 ARP980103146A ARP980103146A AR015917A1 AR 015917 A1 AR015917 A1 AR 015917A1 AR P980103146 A ARP980103146 A AR P980103146A AR P980103146 A ARP980103146 A AR P980103146A AR 015917 A1 AR015917 A1 AR 015917A1
Authority
AR
Argentina
Prior art keywords
solubility
sertralin
compositions
procedure
matter
Prior art date
Application number
ARP980103146A
Other languages
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR015917(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR015917A1 publication Critical patent/AR015917A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Abstract

Una composicion de materia que contiene sertralina o una sal farmacéuticamente aceptable y una cantidad de agente solubilizante suficiente para obtener unaconcentracion de sertralina disuelta en un medio de uso que contiene iones cloruro que sea 1,5veces mayor que la concentracion obtenida por una composicioncomparativa de materia idéntica a la anterior pero sin incluir el mencionado agente solubilizante. Un procedimiento para aumentar la solubilidad de lasertralina en un medio acuoso que contiene ion cloruro, anadiendo la mencionada sertralina al mencionado medio de uso en una composicion de materia queadicionalmente comprende un agente solubilizante.A composition of matter containing sertraline or a pharmaceutically acceptable salt and an amount of solubilizing agent sufficient to obtain a concentration of sertraline dissolved in a medium containing chloride ions that is 1.5 times greater than the concentration obtained by a comparative composition of identical matter to the previous one but not including the mentioned solubilizing agent. A process for increasing the solubility of lasertraline in an aqueous medium containing chloride ion, adding said sertraline to said means of use in a composition of matter queditionally comprises a solubilizing agent.

ARP980103146A 1997-07-01 1998-06-29 COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA AR015917A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
AR015917A1 true AR015917A1 (en) 2001-05-30

Family

ID=21971159

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP980103146A AR015917A1 (en) 1997-07-01 1998-06-29 COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA
ARP030102179A AR040279A2 (en) 1997-07-01 2003-06-19 COMPOSITIONS CONTAINING SERTRALINE SALT
ARP030102180A AR040280A2 (en) 1997-07-01 2003-06-19 PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP030102179A AR040279A2 (en) 1997-07-01 2003-06-19 COMPOSITIONS CONTAINING SERTRALINE SALT
ARP030102180A AR040280A2 (en) 1997-07-01 2003-06-19 PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA

Country Status (34)

Country Link
EP (1) EP0999829A1 (en)
JP (1) JP2000514100A (en)
KR (1) KR100366373B1 (en)
CN (1) CN1261794A (en)
AP (1) AP1192A (en)
AR (3) AR015917A1 (en)
AU (1) AU742535B2 (en)
BG (1) BG103918A (en)
BR (1) BR9810739A (en)
CA (1) CA2290974C (en)
CO (1) CO4940495A1 (en)
DZ (1) DZ2548A1 (en)
EA (1) EA002481B1 (en)
HN (1) HN1998000102A (en)
HR (1) HRP980377A2 (en)
HU (1) HUP0002236A3 (en)
ID (1) ID23429A (en)
IL (1) IL133076A (en)
IS (1) IS5260A (en)
MA (1) MA24587A1 (en)
NO (1) NO996520L (en)
OA (1) OA11243A (en)
PA (1) PA8454301A1 (en)
PE (1) PE97199A1 (en)
PL (1) PL337804A1 (en)
SK (1) SK181099A3 (en)
TN (1) TNSN98124A1 (en)
TR (1) TR199903297T2 (en)
TW (1) TW550087B (en)
UA (1) UA67741C2 (en)
UY (1) UY25071A1 (en)
WO (1) WO1999001120A1 (en)
YU (1) YU68299A (en)
ZA (1) ZA985708B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200200357A (en) 1999-12-23 2003-10-15 Pfizer Products Inc. Pharmaceutical compositions providing increased concentrations of the drug substance
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
JP2004507502A (en) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク Sustained release formulation for growth hormone secretagogue
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
US20100105638A1 (en) * 2007-03-12 2010-04-29 Kerstin Den-Braven Cosmetic compositions
EP2520300A4 (en) * 2009-12-29 2013-05-08 Kowa Co Pharmaceutical composition for oral administration
WO2011081117A1 (en) * 2009-12-29 2011-07-07 興和株式会社 Solid pharmaceutical composition for oral administration
CN109908354A (en) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 Sertraline hydrochloride takes orally concentrate and its preparation process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
ATE96999T1 (en) * 1989-08-30 1993-11-15 Pfizer USE OF SERTRALINE TO TREAT CHEMICAL ADDICTION.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
BG103918A (en) 2000-07-31
SK181099A3 (en) 2000-07-11
KR20010013365A (en) 2001-02-26
AP1192A (en) 2003-07-23
PL337804A1 (en) 2000-09-11
UA67741C2 (en) 2004-07-15
HUP0002236A2 (en) 2003-08-28
CA2290974C (en) 2004-04-27
IL133076A (en) 2003-12-10
ZA985708B (en) 2000-01-10
YU68299A (en) 2002-06-19
NO996520L (en) 2000-02-29
EA199900962A1 (en) 2000-08-28
KR100366373B1 (en) 2003-01-14
PE97199A1 (en) 1999-10-05
IL133076A0 (en) 2001-03-19
CA2290974A1 (en) 1999-01-14
UY25071A1 (en) 2000-12-29
AR040279A2 (en) 2005-03-23
AR040280A2 (en) 2005-03-23
DZ2548A1 (en) 2003-02-08
IS5260A (en) 1999-11-19
WO1999001120A1 (en) 1999-01-14
EP0999829A1 (en) 2000-05-17
NO996520D0 (en) 1999-12-28
BR9810739A (en) 2000-09-12
HN1998000102A (en) 1999-01-08
TR199903297T2 (en) 2000-07-21
TNSN98124A1 (en) 2005-03-15
EA002481B1 (en) 2002-06-27
CN1261794A (en) 2000-08-02
PA8454301A1 (en) 2000-09-29
TW550087B (en) 2003-09-01
JP2000514100A (en) 2000-10-24
AU7544898A (en) 1999-01-25
AP9801280A0 (en) 1998-06-30
MA24587A1 (en) 1998-12-31
ID23429A (en) 2000-04-20
CO4940495A1 (en) 2000-07-24
HUP0002236A3 (en) 2003-12-29
HRP980377A2 (en) 1999-04-30
AU742535B2 (en) 2002-01-03
OA11243A (en) 2003-07-24

Similar Documents

Publication Publication Date Title
AR010579A1 (en) READY TO USE AQUEOUS CLEANING AND DISINFECTION COMPOSITION AND HARD SURFACE DISINFECTION PROCESS.
AR033215A2 (en) CONCENTRATED HERBICIDE COMPOSITION CONTAINING WATER SOLUTION OF POTASSIUM SALTS AND GLYPHANATE MONOETHANOLAMINE AND A TENSIOACTIVE AGENT
ATE312593T1 (en) SKIN CLEANSER FOR INK REMOVAL
BR9509720A (en) Process for the preparation of small particles comprising an organic compound whose solubility is greater in a first water-miscible solvent than in a second solvent which is aqueous and use of the small particles
CO4750721A1 (en) DETERGENT COMPOUND FOR CLEANING TOILETS, ESPECIALLY IN BLOCKS OF THE TYPE "INSIDE THE TANK" OR "BLOCK OF EDGE
DK566686A (en) CLEANING AND / OR DISINFECTION OF CONTACT LENSES
EA199900749A1 (en) PHARMACEUTICAL COMPOSITION
ES2175332T3 (en) DENTIFRICO ANTICALCULES CONTAINING HIGHLY SOLUBLE PYROPHOSPHATE.
AR015917A1 (en) COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA
ES526823A0 (en) PROCEDURE TO OBTAIN STABLE WATER CLEANING AGENT
ES2145907T3 (en) IONOMERIC, STABLE PHOTORRESISTENT EMULSION AND PREPARATION AND USE PROCEDURE.
ES2098964T3 (en) CLEANING AGENT AQUEOUS LIQUID COLLABLES CONCENTRATES II.
MX173001B (en) LIQUID HARD SURFACE DETERGENT COMPOSITIONS CONTAINING IONIC DETERGENT SURFACE AGENT OF ZWITTER AND MONOETHANOLAMINE AND / OR BETA-AMINOALCANOL
ES2051461T3 (en) CONTRAST MEDIA.
HUP0203806A2 (en) Hair treatment composition comprising cationic surfactants with cleansing and conditioning effect
MX169821B (en) CREAMY CLEANING COMPOCITIONS
BG103739A (en) Aqueous pharmaceutical composition containing hard soluble active substance in water
KR920014474A (en) Preparations for Gallstone Collapse
ES2046422T3 (en) ANTIMICROBIAL COMPOSITION AND METHOD OF USE.
DE69403815D1 (en) WASTEWATER TREATMENT WITH HYDROTALCIT
ES2168113T3 (en) WHITENING DISSOLUTION OF LACTONE / PEROXIDE, WHITENING SYSTEM TO FORM THE SAME AND METHOD OF PREPARATION AND USE OF IT.
FR2803205B1 (en) AQUEOUS IONIC SOLUTIONS AND THEIR USES, ESPECIALLY IN OPHTHALMOLOGY
AR020703A1 (en) CLEANING BAR OF HARD SURFACES.
JPS5320656A (en) Method of decoloring colored waste water
NZ332907A (en) Toilet cleansing block containing greater than 3% of a binder selected from cellulose binder or gum

Legal Events

Date Code Title Description
FC Refusal